Perry Elliott

Active 1981–2025

299
Papers
91,737
Citations
133
h-index
286
i10-index

Citations

Citations per year for Perry Elliott1971: 2 citations1979: 1 citations1982: 5 citations1983: 1 citations1984: 3 citations1985: 1 citations1986: 6 citations1987: 3 citations1988: 1 citations1989: 3 citations1990: 4 citations1991: 8 citations1992: 2 citations1993: 3 citations1994: 4 citations1995: 2 citations1996: 3 citations1997: 9 citations1998: 8 citations1999: 16 citations2000: 22 citations2001: 28 citations2002: 30 citations2003: 89 citations2004: 91 citations2005: 108 citations2006: 142 citations2007: 125 citations2008: 187 citations2009: 302 citations2010: 460 citations2011: 478 citations2012: 473 citations2013: 619 citations2014: 700 citations2015: 685 citations2016: 734 citations2017: 637 citations2018: 540 citations2019: 2,111 citations2020: 2,507 citations2021: 2,849 citations2022: 2,016 citations2023: 1,734 citations2024: 3,370 citations2025: 1,515 citations2026: 38 citations1972–1978: no citations, so these years are not shown1980–1981: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,810 citing papers, 17.6% of this breakdownUnited Kingdom: 2,645 citing papers, 9.7% of this breakdownItaly: 2,528 citing papers, 9.3% of this breakdownGermany: 1,758 citing papers, 6.4% of this breakdownNetherlands: 1,408 citing papers, 5.2% of this breakdownChina: 1,182 citing papers, 4.3% of this breakdownFrance: 1,112 citing papers, 4.1% of this breakdownSpain: 1,025 citing papers, 3.7% of this breakdownCanada: 937 citing papers, 3.4% of this breakdownAustralia: 685 citing papers, 2.5% of this breakdownSwitzerland: 670 citing papers, 2.5% of this breakdownJapan: 634 citing papers, 2.3% of this breakdown
0%17.6%Other 29%

Fields

  • Medicine80.3%
  • Biochemistry, Genetics and Molecular Biology14.9%
  • Engineering1.1%
  • Immunology and Microbiology0.7%
  • Computer Science0.6%
  • Health Professions0.6%
  • Other1.8%

Topics

  • Cardiomyopathy and Myosin Studies8.4%
  • Cardiovascular Function and Risk Factors6.8%
  • Cardiovascular Effects of Exercise5%
  • Heart Failure Treatment and Management3.9%
  • Cardiac electrophysiology and arrhythmias3.5%
  • Cardiac pacing and defibrillation studies3.4%
  • Other69%

Coauthors

All papers

Open in search
  1. 2023 ESC Guidelines for the management of cardiomyopathies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Magdy Abdelhamid, Victor Aboyans, Michael Arad, Folkert W. Asselbergs, Riccardo Asteggiano, Zofia T. Bilińska, Damien Bonnet, Henning Bundgaard, Nuno Cardim, Jelena Čelutkienė, Maja Čikeš, Gaetano Maria De Ferrari, Veronica Dusi, Volkmar Falk, Laurent Fauchier, Estelle Gandjbakhch, Tiina Heliö, Konstantinos C. Koskinas, Dipak Kotecha, Ulf Landmesser, George Lazaros, Basil S. Lewis, Aleš Linhart, Maja‐Lisa Løchen, Benjamin Meder, Richard Mindham, James Moon, Jens Cosedis Nielsen, Steffen E. Petersen, Eva Prescott, Mary N. Sheppard, Gianfranco Sinagra, Marta Sitges, Jacob Tfelt‐Hansen, Rhian M. Touyz, Rogier J. A. Veltrop, Josef Veselka, Karim Wahbi, Arthur A.M. Wilde, Katja Zeppenfeld, B. Kichou, Hamayak Sisakian, Daniel Scherr, Bernhard Gerber, Alen Džubur, Мариана Господинова, Ivo Planinc, Hera Heracleous Moustra, David Zemánek, Morten K. Jensen, Ahmad Samir, Kairit Palm, Tiina Heliö, Karim Wahbi, Eric Schulze‐Bahr, Vlachopoulos Haralambos, Róbert Sepp, Berglind Aðalsteinsdóttir, Deirdre Ward, Miry Blich, Gianfranco Sinagra, Afrim Poniku, Olga Lunegova, Ainārs Rudzītis, Roland Kassab, Jūratė Barysienė, Steve Huijnen, Tiziana Felice, Eleonora Vataman, Nikola Pavlović and 41 more - European Heart Journal 2023 cited by 2,384

  2. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 2,709

  3. European Society of Cardiology: cardiovascular disease statistics 2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aurel Demiraj, Mohammed Chettibi, Naima Hammoudi, K Vardanyan, Sergey Pepoyan, Hamayak Sisakian, Daniel Scherr, Peter Siostrzonek, Bernhard Metzer, İsah Mustafayev, Tofig Jahangirov, Yasmin Rustamova, Natalya Mitkovskaya, Natalya Shibeka, Valeriy I Stelmashok, Michel De Pauw, Patrizio Lancellotti, Marc J. Claeys, Zumreta Kušljugić, Alen Džubur, Elnur Smajić, Mariya Tokmakova, Vassil Traykov, Davor Miličić, Marijan Pašalić, Saša Pavasović, Theodoros Christodoulides, Ilias Papasavvas, Christos Eftychiou, Aleš Linhart, Miloš Táborský, Martin Hutyra, Jacob Thorsted Sørensen, Mads Jønsson Andersen, Steen Dalby Kristensen, Magdy Abdelhamid, Khaled Shokry, Priit Kampus, Mika Laine, Matti Niemelä, Bernard Iung, Ariel Cohen, Christophe Leclercq, Dali Trapaidze, Kakhaber Etsadashvili, Alexander Aladashvili, Kurt Bestehorn, Stephan Baldus, Andreas M. Zeiher, John Kanakakis, Alexandria Patrianakos, Christina Chrysohoou, Zoltán Csanádi, Dávid Becker, Zoltán Járai, Þórdís Jóna Hrafnkelsdóttir, Vincent Maher, Jim Crowley, Barbra Dalton, Arik Wolak, Eyal Ben–Assa, Barak Zafrir, Adriano Murrone, Carmen Spaccarotella, Stefano Urbinati, Berkinbayev Salim, Sakhov Orazbek, Abdrakhmanov Ayan, Gani Bajraktari, Docor Afrim Poniku and 84 more - European Heart Journal 2021 cited by 1,108

  4. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aaron L. Baggish, Cristina Basso, Alessandro Biffi, Chiara Bucciarelli‐Ducci, A. John Camm, Guido Claessen, Victoria Delgado, Perry Elliott, Maurizio Galderisi, Chris P Gale, Belinda Gray, Kristina H. Haugaa, Bernard Iung, Hugo A. Katus, Andre Keren, Christophe Leclercq, Basil S Lewis, Lluı́s Mont, Christian Mueller, Steffen E Petersen, Anna Sonia Petronio, Marco Roffi, Kai Savonen, Luis Serratosa, Е. V. Shlyakhto, Iain A Simpson, Marta Sitges, Erik Ekker Solberg, Miguel Sousa‐Uva, Emeline M. Van Craenenbroeck, Caroline M. Van De Heyning, William Wijns, Sabiha Gati, Maria Bäck, Mats Börjesson, Stefano Caselli, Jean-Philippe Collet, Domenico Corrado, Jonathan A. Drezner, Martin Halle, Dominique Hansen, Hein Heidbüchel, Jonathan Myers, Josef Niebauer, Michael Papadakis, Massimo Piepoli, Eva Prescott, Jolien W. Roos‐Hesselink, Graham Stuart, Rod S Taylor, Paul D Thompson, Monica Tiberi, Luc Vanhees, Matthias Wilhelm, Mohamed Tahmi, Parounak Zelveian, Thomas Berger, Rahima Gabulova, Svetlana Sudzhaeva, Patrizio Lancellotti, Šekib Sokolović, I Gruev, Vedran Velagić, Evagoras Nicolaides, Vladimír Tuka, Hanne Rasmusen, Hazem Khamis, Margus Viigimaa, Jari A. Laukkanen, Gilles Bosser and 35 more - European Heart Journal 2020 cited by 1,841

  5. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2013 cited by 3,413

  6. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emeline M. Van Craenenbroeck, Miloš Kubánek, David Zemánek, Morten K. Jensen, Jens Mogensen, Jens Jakob Thune, Philippe Charron, Albert Hagège, Olivier Lairez, Jean‐Noël Trochu, Christoph Axthelm, H DUENGEN, Norbert Frey, Veselin Mitrović, Michael R. Preusch, Jeanette Schulz‐Menger, Tim Seidler, Michael Arad, Majdi Halabi, Amos Katz, Daniel Monakier, Offir Paz, Samuel Viskin, Donna R. Zwas, Iacopo Olivotto, Hans‐Peter Brunner‐La Rocca, Michelle Michels, Dariusz Dudek, Zofia Oko‐Sarnowska, Artur Oręziak, Wojciech Wojakowski, Nuno Cardim, Helder Pereira, Roberto Barriales‐Villa, Pablo García Pavía, Juan Gimeno Blanes, Rafael Hidalgo Urbano, Luis Miguel Rincón Diaz, Perry Elliott, Zaheer Yousef, Theodore P. Abraham, Kia Afshar, Paulino Álvarez, Richard G. Bach, Richard C. Becker, Lubna Choudhury, David Fermin, Daniel Jacoby, John L. Jefferies, Christopher M. Kramer, Neal K. Lakdawala, Steven J. Lester, Ali J. Marian, Ahmad Masri, Matthew J. Maurer, Sherif F. Nagueh, Anjali Owens, David S. Owens, Florian Rader, Sara Saberi, Mark V. Sherrid, Jamshid Shirani, John D. Symanski, Aslan T. Turer, Andrew Wang, Omar Wever‐Pinzon, Matthew T. Wheeler, Timothy C. Wong, Mohamad H. Yamani - The Lancet 2020 cited by 1,210

  7. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2014 cited by 4,317

  8. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2020 cited by 997

  9. 2018 ESC Guidelines for the diagnosis and management of syncope

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ernesto Dı́az-Infante, Victoria Delgado, Faas Dolmans, Oliver Gaemperli, Jacek Gajek, Gerhard Hindricks, Josef Kautzner, Juhani Knuuti, Piotr Kułakowski, Ekaterini Lambrinou, Christophe Leclercq, Philippe Mabo, Carlos A. Morillo, Massimo Piepoli, Marco Roffi, Win K. Shen, Iain A. Simpson, Martin Stockburger, Peter Vanbrabant, Stephan Windecker, José Luis Zamorano, Stephan Windecker, Victor Aboyans, Stefan Agewall, Emanuele Barbato, Héctor Bueno, António Coca, Jean‐Philippe Collet, Ioan Mircea Coman, Verónica Dean, Victoria Delgado, Donna Fitzsimons, Oliver Gaemperli, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A. Katus, Juhani Knuuti, Patrizio Lancellotti, Christophe Leclercq, Theresa McDonagh, Massimo Piepoli, Piotr Ponikowski, Dimitrios Richter, Marco Roffi, Е. V. Shlyakhto, Miguel Sousa‐Uva, Iain A. Simpson, José Luis Zamorano, Franz Xaver Roithinger, Alexandr Chasnoits, Yves Vandekerckhove, Vasil B Traykov, Davor Puljević, Elias Papasavvas, Josef Kautzner, Henning Mølgaard, Mostafa Nawar, Hannu Parikka, Marija Vavlukis, Olivier Piot, Kakhaber Etsadashvili, Thomas Klingenheben, Spyridon Deftereos, László Sághy, Kristján Guðmundsson, Roy Beinart, Antonio Raviele, Ayan Abdrakhmanov, Erkin М Мirrakhimov and 22 more - European Heart Journal 2018 cited by 1,902

  10. Correction: Novel insights into the pathophysiology of hypertrophic cardiomyopathy using label free quantitative proteomics (Heart (2014) 100, Suppl 3 (A89-A90) DOI: 10.1136/heartjnl- 2014-306118.153)

    Authors: , , , , , - ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) 2014 cited by 220

  11. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gonzalo Barón‐Esquivias, Johann Bauersachs, Mauro Biffi, Ulrika Birgersdotter‐Green, Maria Grazia Bongiorni, Michael A. Borger, Jelena Čelutkienė, Maja Čikeš, Jean‐Claude Daubert, Inga Drossart, Kenneth A. Ellenbogen, Perry Elliott, Larissa Fabritz, Volkmar Falk, Laurent Fauchier, Francisco Fernández‐Avilés, Dan Foldager, Fredrik Gadler, Pastora Gallego García de Vinuesa, Bülent Görenek, María José Guerra Palmero, Kristina H. Haugaa, Jeroen Hendriks, Thomas Kahan, Hugo A. Katus, А. О. Конради, Konstantinos C. Koskinas, Hannah Law, Basil S. Lewis, Nicholas J. Linker, Maja‐Lisa Løchen, Joost Lumens, Julia Mascherbauer, Wilfried Müllens, Klaudia Vivien Nagy, Eva Prescott, Pekka Raatikainen, Amina Rakisheva, Tobias Reichlin, Renato Pietro Ricci, Е. V. Shlyakhto, Marta Sitges, Miguel Sousa‐Uva, Richard Sutton, Piotr Suwalski, Jesper Hastrup Svendsen, Rhian M. Touyz, Isabelle C. Van Gelder, Kevin Vernooy, Johannes Waltenberger, Zachary I. Whinnett, Klaus K. Witte - EP Europace 2021 cited by 907

  12. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases

    Authors: , , , , , , , , , , , , , , , - European Heart Journal 2007 cited by 2,998

  13. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , V. Dean, Christi Deaton, Robert Fagard, Christian Funck‐Brentano, David Hasdai, Arno W. Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Theresa A. McDonagh, Bruno Moulin, Bogdan A. Popescu, Željko Reiner, Udo Sechtem, P. A. Sirnes, Michał Tendera, Adam Torbicki, Alec Vahanian, Stephan Windecker, Document Reviewers, Theresa A. McDonagh, Udo Sechtem, Luis Almenar Bonet, Panayiotis Avraamides, Hisham A. Ben Lamin, Michele Brignole, António Coca, Peter J. Cowburn, Henry Dargie, Perry Elliott, Frank A. Flachskampf, Giuseppe Guida, S Hardman, Bernard Iung, Béla Merkely, Christian Mueller, J. Nanas, Olav Wendelboe Nielsen, Stein Ørn, John Parissis, Piotr Ponikowski - European Heart Journal 2012 cited by 6,906

  14. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2016 cited by 1,084

  15. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2020 cited by 682

  16. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

    Authors: , , , , , , , , , , , , - European Heart Journal 2013 cited by 1,220

  17. Cardiac Involvement in Fabry Disease

    Authors: , , , , , , , , , , , , , - Journal of the American College of Cardiology 2021 cited by 309

  18. Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2021 cited by 191

  19. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , - The Lancet 2021 cited by 215

  20. Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy

    Authors: , , , , , , , , , , - Circulation Heart Failure 2021 cited by 193

  21. Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study

    Authors: , , , , , , , , , , - Journal of the American Society of Nephrology 2016 cited by 421

  22. How to develop a more accurate risk prediction model when there are few events

    Authors: , , , , , , - BMJ 2015 cited by 682

  23. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice

    Authors: , , , , , , , , , - JACC Heart Failure 2019 cited by 345

  24. Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy

    Authors: , , , , , , , , , , - European Journal of Heart Failure 2021 cited by 173